Significant improvement was demonstrated in motor function, sensory function, spatial learning and memory.
"We desperately need new treatment avenues for these aggressive brain tumors."
The molecule, called MitoQ stopped spread in 80 percent of cases and recurrence in 75 percent and has been hailed as a 'giant step' by researchers.
Research indicates that the compound does not enter the brain which means it is far less likely to be addictive and cause side effects.